New combo attack on returning prostate cancer shows promise

NCT ID NCT03796767

First seen Jun 27, 2026 · Last updated Jul 23, 2026 · Updated 2 times

Summary

This phase 2 trial is testing whether surgery and radiation can help men whose prostate cancer has come back and spread to a few spots in the body. About 20 participants will receive either surgery to remove the spread tumors or targeted radiation, or both. The main goal is to see if this approach can lower PSA levels by at least half six months after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
surgery (metastasectomy) and radiation therapy (hypofractionated radiation, IMRT, stereotactic body radiation therapy)
What this could lead to
If successful, this could offer a way to control recurrent prostate cancer that has spread to a few spots, potentially delaying disease progression.
What could go wrong
This is a small early-phase trial with only 20 participants, so results may not apply to everyone. The treatment involves surgery and radiation, which carry risks like infection, pain, or damage to nearby tissues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC MALIGNANT NEOPLASM IN THE BONE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Huntsman Cancer Institute/University of Utah

    Salt Lake City, Utah, 84112, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.